475
Views
0
CrossRef citations to date
0
Altmetric
Research Reports

A proposal for an updated staging system for LCHADD retinopathy

, , , , , , , , ORCID Icon, , , & show all
Pages 140-146 | Received 09 Aug 2023, Accepted 05 Jan 2024, Published online: 30 Jan 2024

References

  • Rinaldo P, Matern D, Bennett MJ. Fatty acid oxidation disorders. Annu Rev Physiol. 2002;64(1):477–502. doi:10.1146/annurev.physiol.64.082201.154705.
  • Xia C, Fu Z, Battaile KP, Kim JP. Crystal structure of human mitochondrial trifunctional protein, a fatty acid β-oxidation metabolon. Proc Natl Acad Sci USA. 2019;116(13):6069–74. doi:10.1073/pnas.1816317116.
  • Liang K, Li N, Wang X, Dai J, Liu P, Wang C, Chen XW, Gao N, Xiao J. Cryo-EM structure of human mitochondrial trifunctional protein. Proc Natl Acad Sci USA. 2018;115(27):7039–7044. doi:10.1073/pnas.1801252115.
  • Fletcher AL, Pennesi ME, Harding CO, Weleber RG, Gillingham MB. Observations regarding retinopathy in mitochondrial trifunctional protein deficiencies. Mol Genet Metab. 2012;106(1):18–24. doi:10.1016/j.ymgme.2012.02.015.
  • Boutron A, Acquaviva C, Vianey-Saban C, de Lonlay P, de Baulny HO, Guffon N, Dobbelaere D, Feillet F, Labarthe F, Lamireau D, et al. Comprehensive cDNA study and quantitative analysis of mutant HADHA and HADHB transcripts in a French cohort of 52 patients with mitochondrial trifunctional protein deficiency. Mol Genet Metab. 2011;103(4):341–348. doi:10.1016/j.ymgme.2011.04.006.
  • IJ L, Ruiter JP, Hoovers JM, Jakobs ME, Wanders RJ. Common missense mutation G1528C in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Characterization and expression of the mutant protein, mutation analysis on genomic DNA and chromosomal localization of the mitochondrial trifunctional protein alpha subunit gene. J Clin Invest. 1996;98(4):1028–33. doi:10.1172/JCI118863.
  • Vockley J, Bennett MJ, Gillingham MB. Mitochondrial fatty acid oxidation disorders. In: Valle D, Antonarakis S, Ballabio A, Beaudet A, and Mitchell G, editors. The online metabolic and molecular bases of inherited disease. New York, NY: McGraw-Hill Education; 2019. https://ommbid.mhmedical.com/content.aspx?bookid=2709§ionid=247995158.
  • Fahnehjelm KT, Liu Y, Olsson D, Amrén U, Haglind CB, Holmström G, Halldin M, Andreasson S, Nordenström A. Most patients with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency develop pathological or subnormal retinal function. Acta Paediatr. 2016;105(12):1451–1460. doi:10.1111/apa.13536.
  • Tyni T, Kivelä T, Lappi M, Summanen P, Nikoskelainen E, Pihko H. Ophthalmologic findings in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency caused by the G1528C mutation: a new type of hereditary metabolic chorioretinopathy. Ophthalmology. 1998;105(5):810–824. doi:10.1016/S0161-6420(98)95019-9.
  • Spiekerkoetter U. Mitochondrial fatty acid oxidation disorders: clinical presentation of long-chain fatty acid oxidation defects before and after newborn screening. J Inherit Metab Dis. 2010;33(5):527–532. doi:10.1007/s10545-010-9090-x.
  • Tyni T, Pihko H. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Acta Paediatr. 1999;88(3):237–245. doi:10.1111/j.1651-2227.1999.tb01089.x.
  • Gillingham M, Van Calcar S, Ney D, Wolff J, Harding C. Dietary management of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD). A case report and survey. J Inherit Metab Dis. 1999;22(2):123–131. doi:10.1023/A:1005437616934.
  • Schrijver-Wieling I, van Rens GHMB, Wittebol-Post D, Smeitink JAM, de Jager JP, de Klerk HBC, van Lith GHM. Retinal dystrophy in long chain 3-hydroxy-acyl-coA dehydrogenase deficiency. Br J Ophthalmol. 1997;81(4):291. doi:10.1136/bjo.81.4.291.
  • Lim CC, Vockley J, Ujah O, Kirby RS, Edick MJ, Berry SA, Arnold GL. Outcomes and genotype correlations in patients with mitochondrial trifunctional protein or isolated long chain 3-hydroxyacyl-CoA dehydrogenase deficiency enrolled in the IBEM-IS database. Mol Genet Metab Rep. 2022;32:100884. doi:10.1016/j.ymgmr.2022.100884.
  • Tyni T, Immonen T, Lindahl P, Majander A, Kivelä T. Refined staging for chorioretinopathy in long-chain 3-hydroxyacyl coenzyme a dehydrogenase deficiency. Ophthalmic Res. 2012;48(2):75–81. doi:10.1159/000334874.
  • Fricker SJ, Sanders JJ. Ergs and noise: detection probability, time and amplitude errors. In: Dodt E Pearlman J, editors. Xith ISCERG symposium. Dordrecht: Springer; 1974. pp. 395–408.
  • Rispoli E, Iannaccone A, Vingolo EM. Low-noise electroretinogram recording techniques in retinitis pigmentosa. Doc Ophthalmol. 1994;88(1):27–37. doi:10.1007/BF01203699.
  • Yamashita T, Miki A, Tabuchi A, Funada H, Kondo M. A novel method to reduce noise in electroretinography using skin electrodes: a study of noise level, inter-session variability, and reproducibility. Int Ophthalmol. 2017;37(2):317–324. doi:10.1007/s10792-016-0240-5.
  • Man TTC, Yip YWY, Cheung FKF, Lee WS, Pang CP, Brelén ME. Evaluation of electrical performance and properties of electroretinography electrodes. Transl Vis Sci Technol. 2020;9(7):45. doi:10.1167/tvst.9.7.45.
  • Yip YWY, Man TC, Pang CP, Brelén ME. Improving the quality of electroretinogram recordings using active electrodes. Exp Eye Res. 2018;176:46–52. doi:10.1016/j.exer.2018.06.007.
  • Sacconi R, Bandello F, Querques G. Choroidal neovascularization associated with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Retin Cases Brief Rep. 2022;16(1):99–101. doi:10.1097/ICB.0000000000000923.
  • Wongchaisuwat N, Wang J, Yang P, Everett L, Gregor A, Sahel JA, Nischal KK, Pennesi ME, Gillingham MB, Jia Y. Optical coherence tomography angiography of choroidal neovascularization in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD). Am J Ophthalmol Case Rep. 2023;32:101958. doi:10.1016/j.ajoc.2023.101958.
  • Tyni T, Paetau A, Strauss AW, Middleton B, Kivelä T. Mitochondrial fatty acid beta-oxidation in the human eye and brain: implications for the retinopathy of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Pediatr Res. 2004;56(5):744–50. doi:10.1203/01.PDR.0000141967.52759.83.
  • Polinati PP, Ilmarinen T, Trokovic R, Hyotylainen T, Otonkoski T, Suomalainen A, Skottman H, Tyni T. Patient-specific induced pluripotent stem cell–derived RPE cells: understanding the pathogenesis of retinopathy in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Invest Ophthalmol Visual Sci. 2015;56(5):3371–3382. doi:10.1167/iovs.14-14007.
  • Iriyama A, Aihara Y, Yanagi Y. Outer retinal tubulation in inherited retinal degenerative disease. Retina. 2013;33(7):1462–1465. doi:10.1097/IAE.0b013e31828221ae.
  • Sun LW, Johnson RD, Williams V, Summerfelt P, Dubra A, Weinberg DV, Stepien KE, Fishman GA, Carroll J, Wen R. Multimodal Imaging of Photoreceptor Structure in Choroideremia. PloS One. 2016;11(12):e0167526. doi:10.1371/journal.pone.0167526.
  • Fahnehjelm KT, Holmström G, Ying L, Haglind CB, Nordenström A, Halldin M, Alm J, Nemeth A, Von Döbeln U. Ocular characteristics in 10 children with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: a cross-sectional study with long-term follow-up. Acta Ophthalmol. 2008;86(3):329–337. doi:10.1111/j.1755-3768.2007.01121.x.
  • Gillingham MB, Weleber RG, Neuringer M, Connor WE, Mills M, Van Calcar S, Ver Hoeve J, Wolff J, Harding CO. Effect of optimal dietary therapy upon visual function in children with long-chain 3-hydroxyacyl CoA dehydrogenase and trifunctional protein deficiency. Mol Genet Metab. 2005;86(1–2):124–133. doi:10.1016/j.ymgme.2005.06.001.